BIOHARVEST SCIENCES INC. (CNVCF)
NASDAQ NASDAQ Primary Summary
CNVCF Chart
BioHarvest Sciences sees record VINIA sales in May
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) announced that sales of its flagship product VINIA increased to record levels in May 2024 due to strong subscription rates and the successful introduction of new products, such as VINIA Superfood Coffee. This surge was fueled by BioHarvest Sciences' effective Direct-to-Consumer sales strategy, which led to a significant rise in new customers and subscribers.
BioHarvest Sciences sees Q1 revenue surge above guidance on strong VINIA sales
BioHarvest Sciences Inc. (CSE:BHSC, OTC:CNVCF) saw its first quarter revenue surge almost 150% over the year-ago period driven by continued strong sales of its VINIA red grape superfood. Revenue for the quarter was US$5.34 million, up from US$2.2 million in the year-ago quarter and up 18% sequentially.
BIOHARVEST SCIENCES INC. (CNVCF) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BIOHARVEST SCIENCES INC. ever had a stock split?
BIOHARVEST SCIENCES INC. Profile
| Food Products Industry | Consumer Staples Sector | Ilan Sobel CEO | NASDAQ Exchange | CA09076J1084 ISIN |
| CA Country | - Employees | - Last Dividend | 3 Jun 2024 Last Split | - IPO Date |
Overview
BioHarvest Sciences Inc. stands as a pioneering biotechnology firm engaged in the development of a unique botanical synthesis platform technology. This innovative approach allows for the cultivation of essential ingredients found in various fruits and plants without the necessity of growing the plant itself. The company’s endeavors are grounded in the application of this technology across the nutraceuticals and pharmaceuticals sectors, aiming to deliver scientifically backed and clinically verified therapeutic solutions. Furthermore, BioHarvest Sciences Inc. functions as a contract development and production organization (CDMO), offering services to clients in need of diverse molecules, in addition to creating its own range of nutraceutical health and wellness products, including dietary supplements. With its headquarters in Vancouver, Canada, the company expands its operational footprint across Israel and the United States, positioning itself as a leader in integrating technology with nature to advance health and wellness.
Products and Services
- VINIA
VINIA is a groundbreaking red grape cell dietary supplement, developed by BioHarvest Sciences Inc., that encapsulates the complex matrix of polyphenols found within red grapes. This product emerges from the company’s proprietary botanical synthesis platform technology, which enables the production of essential fruit and plant ingredients without the cultivation of the plants themselves. By harnessing this technology, VINIA offers a unique composition that promotes various health benefits associated with the natural compounds present in red grapes, providing a scientifically advanced approach to dietary supplementation.
- Contract Development and Production Organization (CDMO) Services
Aside from its product offerings, BioHarvest Sciences Inc. extends its technological and production capabilities as a contract development and production organization (CDMO). This aspect of the company’s operations involves partnering with clients seeking the production of various molecules for different applications. Through this service, BioHarvest Sciences Inc. leverages its botanical synthesis platform technology and extensive biotechnological expertise to aid clients in bringing their innovative molecule-based products to market, thereby playing a crucial role in the broader biotechnology and pharmaceutical industries.
